TBA Law Blog


Posted by: Julia Wilburn on Mar 26, 2024

The U.S. Supreme Court this week heard oral arguments in a case that could have sweeping consequences for all Americans’ access to mifepristone, a widely used abortion pill. According to The Hill, the court is essentially being asked to uphold an appeals court ruling that overrides a series of changes made by the Food and Drug Administration over the past decade, including increasing the gestational age at which mifepristone can be used to up to 10 weeks of pregnancy, allowing the medication to be mailed to patients, lowering the dosage, allowing telehealth prescribing and permitting providers other than physicians to prescribe the drug.